GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Additional Paid-In Capital

Kobayashi Pharmaceutical Co (TSE:4967) Additional Paid-In Capital : 円522 Mil(As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Additional Paid-In Capital?


Kobayashi Pharmaceutical Co's quarterly additional paid-in capital stayed the same from Sep. 2023 (円522 Mil) to Dec. 2023 (円522 Mil) and stayed the same from Dec. 2023 (円522 Mil) to Mar. 2024 (円522 Mil).

Kobayashi Pharmaceutical Co's annual additional paid-in capital declined from Dec. 2021 (円4,183 Mil) to Dec. 2022 (円522 Mil) but then stayed the same from Dec. 2022 (円522 Mil) to Dec. 2023 (円522 Mil).

Kobayashi Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Additional Paid-In Capital Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,183.00 4,183.00 4,183.00 522.00 522.00

Kobayashi Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 522.00 522.00 522.00 522.00 522.00

Kobayashi Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Kobayashi Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Additional Paid-In Capital
Comparable Companies
TSE:4912 TSE:4927 TSE:4922 TSE:8283 TSE:4921 TSE:7956 TSE:4928 TSE:4527 TSE:4919 TSE:4985 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
KOY:Germany
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Website
https://www.kobayashi.co.jp
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines